永勝醫療(01612.HK)收購VMHK及VMDG其餘股本權益
格隆匯 10 月 30日丨永勝醫療(01612.HK)公告,於2020年10月30日,公司與Bayer Medical Care就收購事項訂立股份轉讓協議。根據股份轉讓協議,公司(作為買方)有條件同意以代價6729.36萬港元向Bayer Medical Care(作為賣方)收購銷售股份。
"銷售股份"指Bayer Medical Care持有的VMHK的1,718,861股股份(佔其已發行股份約19.90%)以及VMDG的3.98%股本權益。
於本公告日期,完成已於支付代價後作實。因此,(i)VMHK及VMDG已成為公司的間接全資附屬公司;及(ii)BayerMedicalCare不再是本公司的關連人士。
集團主要從事研發、製造及銷售醫療器械,專注於呼吸支援、成像劑壓力注射器一次性產品以及骨科支護復康器具產品。
BayerMedicalCare開發、製造及銷售用於血管造影、計算機斷層掃描及磁力共振成像的設備和產品。BayerMedicalCare是德國跨國製藥及生命科學公司BayerAG的全資附屬公司。
收購事項將讓集團獲得對其OEM業務分部的完全控制權,以實現服務組合和客户羣的多元化,並可通過省卻為股東溝通所投入的資源而提高營運效率。由於Bayer集團是集團的其中一名主要客户,收購事項亦將縮減公司的關連交易規模。
此外,代價為合理而收購事項當可增加集團的價值。董事會已評估收購事項對集團目前與Bayer集團業務的影響,並相信集團未來將繼續與Bayer集團保持強大及彼此信守的長期業務關係。根據與Bayer集團的現有供應協議,集團最近獲得一個新的OEM項目,為Bayer集團開發及生產若干新的計算機斷層掃描注射器耗材。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.